Avion Pharmaceuticals, LLC., announces further expansion of their Women's Health Sales Team

ATLANTA, April 16, 2013 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, announces the addition of 45 sales representatives to support their Women's Health Care and Dermatology portfolio of products.  The new sales team has joined the existing 40 representatives in promoting the Prenate® prenatal vitamin family of products along with Nicomide® for inflammatory acne.  In addition, the expanded Avion sales team of 85 representatives will be focused on the launch of FeRiva™ a new prescription iron supplement.  FeRiva delivers two forms of iron utilizing a patented INNER CAP multi-compartment capsule technology.  FeRiva contains 75 mg of elemental iron that includes Ferrochel® (Ferrous Bis-glycinate Sulfate and Ferronyl® (Carbonyl Iron), two preferred forms of iron for improved tolerability and compliance.

"The expansion of our sales team provides the critical level of sales support needed to effectively promote our portfolio of products to our prescriber community.  Avion is well-positioned for continued growth by providing a suite of products that will meet patient needs and our team of sales professionals is poised for success," stated Mike Sullivan, Vice President, Sales and Marketing for Avion Pharmaceuticals. 

"Avion Pharmaceuticals is excited to continue our focused efforts on nurturing the health and nutritional needs of women.  Our sales force expansion is being executed at the optimal juncture in our corporate history to support the progress we have planned for continued growth," added Mark Pugh, CEO for Avion Pharmaceuticals.

About Avion Pharmaceuticals, LLC.
Avion Pharmaceuticals, LLC. is a Specialty Pharmaceutical company formed to develop and market a portfolio of innovative pharmaceutical products in the Women's Heath and Dermatology therapeutic areas.  Avion Pharmaceuticals focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available therapeutics and late-stage development drugs to fulfill unmet medical needs.  For additional information about Avion Pharmaceuticals please contact the company at 678-325-5188.

Ferronyl is a registered trademark of ISP Investments, Inc. PureWay-C is a registered trademark of Innovation Laboratories, Inc. Ferrochel is a registered trademark of Albion Laboratories, Inc. covered by U.S. Patents 6,716,814 & 7,838,042.
Covered by one or more claims of U.S. Patent # 7,670,612 (INNERCAP Technologies, Inc).

FeRiva™ is a trademark of Avion Pharmaceuticals, LLC. Under license from Acella Pharmaceuticals, LLC. All rights reserved.

SOURCE Avion Pharmaceuticals, LLC.